Share on StockTwits

Intrexon Corp (NYSE:XON) is set to post its Q214 quarterly earnings results on Thursday, August 14th. Analysts expect Intrexon Corp to post earnings of ($0.13) per share and revenue of $9.39 million for the quarter.

Shares of Intrexon Corp (NYSE:XON) opened at 21.90 on Wednesday. Intrexon Corp has a 1-year low of $13.13 and a 1-year high of $38.50. The stock’s 50-day moving average is $23.59 and its 200-day moving average is $24.08. The company’s market cap is $2.164 billion.

Intrexon Corporation is engaged in the business of synthetic biology. Using the Company’s suite of complementary technologies, it design, build and regulate gene programs, or sequences of deoxyribonucleic acid (NYSE:XON) that control cellular function, and cellular systems, or activities that take place within a cell and the interaction of those systems in the greater cellular environment, to enable the development of new and improved products and manufacturing processes across a variety of end markets, including healthcare, food, energy and environmental sciences.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.